Pharma Company

Transforming Clinical Trials Supply Chain Management with Sustainability

About the Client

A leading biopharmaceutical company faced challenges in reducing medicine waste during high-cost clinical trials. Up to 70% of medicines were wasted due to unpredictable patient recruitment, retention, and dosing, leading to financial, ethical, and environmental concerns.

The Challenge

Randomised clinical studies produced significant medicine waste, increasing costs, ethical issues, and environmental impact. Traditional supply chain tools lacked predictive capabilities, relying heavily on user experience and exacerbating inefficiencies.

The Solution

MOAT introduced an Advanced Analytics, Optimisation, and Machine Learning (AAOML) tool to transform supply chain management with complex system integrations and data cleansing. Key actions included:

Optimised Study Design: Using simulations to refine parameters like country selection and visit schedules.

Collaboration: Engaging experts to address inefficiencies and enhance patient retention forecasts.

Capability Building: Creating workflows, training programmes, and processes for long-term improvements.

Saved
$ 0 m
Waste Reduction
0 %

The Outcome

Waste Reduction: Lowering waste from 70% to 37%, reducing costs and environmental impact.

Cost Savings: Generating significant budget savings.

Enhanced Capabilities: Establishing industry-leading workflows and benchmarks.

Ready to transform your business?

Contact us today to discuss your needs and discover how our expert, tailored solutions can drive lasting results.

Related Case Studies

One Family

Streamlining Operations for a Financial Services Subsidiary

InterTradeIreland

Streamlining Supply Chains for Cross-Border Growth

Global Bio-Pharmaceutical

Optimising Supply Chain and Procurement for a Biopharmaceutical Leader